Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy.

Journal of gastroenterology - 1 Feb 2014

Su Tung-Hung, Liu Chun-Jen, Yang Hung-Chih, Jeng Yung-Ming, Cheng Huei-Ru, Liu Chen-Hua, Tseng Tai-Chung, Ling Thai-Yen, Chen Pei-Jer, Chen Ding-Shinn, Kao Jia-Horng

Abstract excerpt

BACKGROUND: Serum hepatitis B surface antigen (HBsAg) level is important in the management of chronic hepatitis B (CHB). However, it is unclear whether serum HBsAg reflects its expression in liver and the hepatic HBsAg evolution following interferon therapy. METHODS: Forty-five HBeAg-positive CHB...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Hepatitis B, Chronic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B e Antigens

Share to Hepatitis B Surface Antigens

Share to Hepatitis B virus

Share to Hepatocytes

Share to Interferon-alpha

Share to Interferon alpha-2

Source

Identifiers

PMID: 23736797
DOI: 10.1007/s00535-013-0840-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23736797-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy.PMID 23736797Read ↗

Clinical significance of serum HBsAg levels and association with liver histology in HBeAg positive chronic hepatitis B.Semantic proximity Read ↗

HBsAg expression of liver correlates with histological activities and viral replication in chronic hepatitis B.Semantic proximity Read ↗

The clinical significance and optimization strategies of HBeAg seroclearance in chronic hepatitis B treatment.Semantic proximity Read ↗

Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog.Semantic proximity Read ↗

Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.Semantic proximity Read ↗

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.Semantic proximity Read ↗

Immunopathology on hepatocyte expression of HBV surface, core, and x antigens in chronic hepatitis B: clinical and virological correlation.Semantic proximity Read ↗

Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected LiverSemantic proximity Read ↗

HBsAg protein composition and clinical outcomes in chronic hepatitis D and variations across HBeAg-negative chronic HBsAg carriersSemantic proximity Read ↗

Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia.Semantic proximity Read ↗

Early hepatitis B surface antigen decline predicts treatment response to entecavir in patients with chronic hepatitis B.Semantic proximity Read ↗

Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.